S-1: Ethos Technologies Files S-1 for IPO, Reveals Strong Growth
Initial Public Offering Registration Statement
Ethos Technologies Inc., a digital life insurance platform, filed its S-1 registration statement, showcasing significant revenue growth and profitability ahead of its initial public offering.
Summary
- Ethos Technologies is a technology company transforming the life insurance industry with a three-sided platform for consumers, agents, and carriers.
- The platform offers a 100% digital application and underwriting process, providing decisions in minutes for most consumers.
- It empowers agents with an 'Agent OS' for streamlined sales, quick payments, and policy management.
- Carriers benefit from expanded reach, optimized risk selection, and efficient policy administration without assuming balance sheet risk.
- Since inception, Ethos has activated over 450,000 policies, and as of June 30, 2025, it had over 10,000 active selling agents and several active carriers.
- Revenue increased by 60% from $160 million in 2023 to $255 million in 2024.
- Net income margin improved from 1% in 2023 to 19% in 2024, and Adjusted EBITDA margin increased from 4% in 2023 to 23% in 2024.
- For the six months ended June 30, 2025, revenue was $184 million (up 55% year-over-year), net income margin was 17%, and Adjusted EBITDA margin was 24%.
- The company plans to launch two new products, Cancer Insurance and Accumulation Indexed Universal Life Insurance, by the end of 2025.
Sentiment
Score: 8
Explanation: The filing demonstrates exceptional growth in a large, underserved market, coupled with a proven path to profitability and strong margins. Its vertically integrated, data-driven platform provides a significant competitive advantage, evidenced by high customer satisfaction (NPS of 70) and efficient product development. The company's ability to attract and retain both consumers and a growing network of agents, while deepening relationships with major carriers, positions it for continued market share expansion. While risks associated with growth, competition, and regulatory environment exist, the overall financial trajectory, innovative business model, and clear growth strategies make it a compelling investment opportunity for long-term growth. The planned product expansion into Cancer Insurance and Accumulation Indexed Universal Life Insurance further diversifies revenue streams and addresses broader market needs.
Positives
- Strong revenue growth: 60% increase from $160 million (2023) to $255 million (2024), and 55% increase from $119 million (H1 2024) to $184 million (H1 2025).
- Achieved and sustained profitability: Net income margin improved from 1% (2023) to 19% (2024), and 16% (H1 2024) to 17% (H1 2025).
- Significant Adjusted EBITDA margin improvement: From 4% (2023) to 23% (2024), and 18% (H1 2024) to 24% (H1 2025).
- High gross margin: Consistently around 96-98%.
- Rapid policy activation: Over 450,000 policies activated since inception, with a 70% increase in H1 2025 vs H1 2024.
- Efficient customer acquisition: Average payback period for new policies within two months as of June 30, 2025.
- Strong agent network: Over 10,000 active selling agents as of December 31, 2024, with increasing productivity per agent.
- Deep carrier relationships: Largest source of life insurance premiums for top three longest-tenured carriers in 2024, with an average CAGR of 64% in annual premiums through Ethos from 2021-2024.
- Extensible technology platform: Ability to rapidly launch and scale new products (from 1 in 2019 to 10 in 2024), with faster time-to-market for new products (e.g., recent Term Life product achieved $20 million run-rate in 15 months vs. 24 months previously).
- Proprietary underwriting engine: Delivers instant decisions for 95% of applicants based on internal data, leveraging up to 250,000 data points per application.
- High customer satisfaction: NPS score of 70, significantly above the carrier industry average of 14.
- Capital and asset-light business model: Does not assume balance sheet risk for policies.
- Diversified go-to-market strategy: Leverages both direct-to-consumer (DTC) and third-party channels.
- Significant data moat: Vertically integrated platform collects extensive data, refining underwriting accuracy and pricing efficiency.
- Early mover advantage: Established strategic relationships with leading insurance carriers since 2018.
- Planned product expansion: Two additional products (Cancer Insurance and Accumulation Indexed Universal Life Insurance) planned by end of 2025 without additional financing.
Negatives
- History of net losses since inception (2016), only recently achieved profitability in 2023.
- Limited operating history at current scale and complexity makes future forecasting difficult.
- Fluctuations in persistency estimates can negatively impact revenue and cash flows, especially with new carriers or products.
- Dependence on a limited number of carriers (top three represented 98% of total revenue in 2023 and 2024).
- Reliance on a limited number of agency counterparties (three most significant agencies generated 17% and 25% of revenue in 2023 and 2024, respectively).
- Risk of increased agent compensation demands impacting margins.
- Business depends on third-party data, technology, and infrastructure providers; loss of access or changes could harm operations.
- Cybersecurity risks, data breaches, and system failures could adversely affect business and reputation.
- Brand awareness and marketing efforts may not be effective or cost-efficient.
- Volatility in results of operations and operating cash flows expected quarterly/annually.
- Changes in accounting estimates (e.g., persistency) can affect financial position.
- Inability to fully or promptly recoup agent payments upon policy terminations.
- Subject to extensive and evolving regulations, including state insurance laws, consumer protection, data privacy, and AI use.
- Intense and fragmented competition in the insurance industry.
- Stock price may be volatile, and an active public trading market may not develop or be sustained.
- Broad discretion in use of IPO proceeds, which may not be used effectively.
- Immediate and substantial dilution for new investors in the IPO.
- No intention to pay dividends for the foreseeable future.
- Identified a material weakness in internal control over financial reporting related to accounting for the sale of commissions receivable.
- Management team has limited experience managing a public company.
- Climate risks could adversely affect business.
- Employees may be subject to claims alleging violations of contractual obligations to prior employers.
- Ability to use net operating losses (NOLs) may be limited.
Risks
- History of losses; may not sustain profitability.
- Limited operating history at current scale, scope, and complexity, making future planning and prediction difficult.
- Inability to accurately forecast persistency estimates, leading to unexpected revenue and cash flow differences.
- Business could be harmed by failure to manage growth effectively.
- Revenue depends on carrier-set premiums and negotiated commission rates; changes or repayment obligations could impact revenue.
- Loss of, or failure to maintain good relationships with, carriers, or increased dependence on a limited number of carriers.
- Reliance on a limited number of agency counterparties; failure to maintain these relationships could harm results.
- Success depends on individual agent adoption and engagement; lack thereof could harm results.
- Dependence on third-party data, technology, and infrastructure providers; failure to maintain relationships or changes in services could adversely affect operations.
- Cyber attacks, data breaches, security incidents, and system failures could adversely affect business.
- Brand awareness and marketing efforts may not be effective.
- Damage to reputation could have a material adverse effect.
- Failure to obtain, maintain, protect, defend, or enforce intellectual property rights, or allegations of infringement.
- Subject to disputes, legal proceedings, and governmental inquiries and investigations.
- Subject to stringent and evolving U.S. laws, regulations, and rules, contractual obligations, and industry standards related to data privacy and security.
- Identified a material weakness in internal control over financial reporting.
- Intense competition in the industry.
- Stock price may be volatile.
- No public market for Class A common stock currently exists; active market may not develop or be sustained.
- Broad discretion in use of net IPO proceeds.
- Future sales of Class A common stock could cause price decline.
- Substantial tax obligations on initial RSU settlement may dilute stockholders.
- May require additional capital, which might not be available on acceptable terms.
- Immediate and substantial dilution for new investors.
- No intention to pay dividends for the foreseeable future.
- Emerging growth company status may make Class A common stock less attractive.
- Increased costs and management time due to public company responsibilities.
- Anti-takeover provisions in charter documents and Delaware law.
- Designation of Delaware courts and federal district courts as exclusive forums for certain disputes.
- Securities or industry analysts not publishing research or publishing unfavorable research.
- Inability to successfully recover from disaster or business continuity problems.
- Inability to apply technology effectively or gain internal efficiencies.
- Results may be adversely affected by changes in insurance industry compensation mode.
- New user growth could decline if not prominent in search results.
- Changes in accounting estimates and assumptions could negatively affect financial position.
- Ability to recoup payments from agents and timing of recoupment may impact business.
- Non-compliance with or changes in laws, regulations, or licensing requirements.
- Fluctuations or overall decline in economic activity, or adverse trends in life insurance industry.
- Use of artificial intelligence may expose to regulatory, operational, or reputational risk.
- Inability to retain or hire qualified employees, or loss of executive officers.
- Failure to offer high-quality support for the platform.
- Reliance on third-party cloud service providers.
- Negative impact from E&O claims.
- Risks associated with acquisitions, dispositions, and new lines of business.
- Failure to improve and enhance platform functionality and innovate.
- Ability to use net operating losses (NOLs) may be limited.
- Subject to additional tax liabilities, including from changes in tax laws.
- Management team has limited experience managing a public company.
- Climate risks.
Future Outlook
We expect to make significant investments in marketing, advertising, research, and development to expand the business and offerings, anticipating continued growth in activated policies, carrier and agency relationships, and product offerings. Sales and marketing, general and administrative, and technology expenses are projected to increase on an absolute dollar basis, with cost of revenue increasing absolutely but remaining relatively consistent as a percentage of revenue. Adjusted EBITDA and Contribution Profit/Margin are expected to fluctuate in the near term due to investments but improve over the long term with scale and efficiency. We plan to launch two additional products, Cancer Insurance and Accumulation Indexed Universal Life Insurance, by the end of 2025, without additional financing. A net loss is expected for the quarter and year of the IPO due to significant stock-based compensation expense from RSU settlement.
Management Comments
- Our mission is to protect families by democratizing access to life insurance and empowering agents at scale.
- The life insurance industry was as confusing to us as outsiders as it was to consumers and agents. We built Ethos to democratize access to life insurance.
- Our technology platform and underwriting engine transforms the buying, selling and risk management of life insuranceso families can secure affordable coverage in minutes, not months.
- We also empower agents livelihoods. By making the selling process instant, paying next-day commissions and delivering an industry-leading agent technology suite, Ethos can dramatically change the earnings potential of an agent.
- Backing the promises of these policies are our valued life insurance carriers. We have the trusted position of managing risk on their behalf and we always put their underwriting profitability before our own profitability.
- We have consistently demonstrated strong risk management capabilities and delivered meaningful policyholder scale.
- When a father in rural Texas or a single mother in Minnesota gets coverage, a household gains security, an agent earns, and a carrier grows responsibly. We are proud to serve each of our constituents.
- Our greatest competitive advantage is our people and culture. We are inspired to protect families, empower agents and grow our carriers and know we need to consistently earn their trust.
- Our culture is reflected in our values: Serve our Families. Bias for Impact. Intellectual Rigor. Speak your mind. We win together: one team, one dream.
- Ethos is a low, single-digit percentage of the life insurance industry today. By building a high-NPS, vertically-integrated technology platform that transforms the life insurance experience for consumers, agents and carriers we are well-positioned to seize the opportunity before us and transform the industry.
Industry Context
The U.S. life insurance market is vast and driven by millions of annual life events, yet 42% of American adults in 2024 recognized a need for coverage but were deterred by perceived cost and complexity. Traditional insurers, many over 100 years old, struggle with outdated infrastructure. The industry is shifting towards independent agents (53% of premiums in 2023, up 8% from 2013), and there's growing consumer demand for direct-to-consumer digital sales, mirroring trends in auto insurance (e.g., Progressive's 56% DTC personal auto premiums in 2024). The sector is also seeing significant private equity investment and disruption from Insurtech startups leveraging AI and digital platforms, alongside increasing regulatory scrutiny on AI use in underwriting.
Comparison to Industry Standards
- Ethos's digital technology platform delivers underwriting decisions for the majority of applicants within ten minutes, significantly faster than the four to eight weeks on average for traditional underwriting processes.
- Ethos boasts an NPS score of 70, which is substantially higher than the carrier industry average of 14.
- Ethos launched one of its most recent Term Life Insurance products in less than half of the industry average product development time, based on average timelines cited in a 2023 Deloitte study.
- The shift towards independent agents, who distributed 53% of premiums in 2023 (up 8% from 2013 according to LIMRA), aligns with Ethos's third-party channel strategy, positioning it favorably within evolving distribution models.
- The U.S. auto insurance sector, with Progressive writing 56% of its personal auto premiums through DTC channels in 2024, demonstrates a consumer preference for digital end-to-end experiences that Ethos is leveraging in the life insurance market.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | Kunal Mehta | Christopher Capozzi | April 2025 | Appointment of new CFO |
| Senior Vice President, Finance | N/A | Kunal Mehta | April 2025 | Transition from CFO role |
| Director | N/A | William J. Wheeler | July 2025 | Appointment to the board |
| Lead Independent Director | N/A | Roelof Botha | Upon IPO closing | Appointment to new role |
| Audit Committee Chairperson | N/A | Khozema Shipchandler | Upon IPO closing | Appointment to new role |
| Compensation Committee Chairperson | N/A | John Kunze | Upon IPO closing | Appointment to new role |
| Nominating and Corporate Governance Committee Chairperson | N/A | William J. Wheeler | Upon IPO closing | Appointment to new role |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Investor Rights Agreement | Amended and Restated Investor Rights Agreement (IRA) entered into as of July 26, 2021, amending and restating a prior agreement from April 30, 2021. It grants registration rights, information rights, and other rights to Investors. | July 26, 2021 | Formalizes and updates investor rights, including registration and information access, crucial for pre-IPO investors. |
| Certificate of Incorporation & Bylaws | Amended and Restated Certificate of Incorporation and Bylaws will become effective immediately prior to the IPO closing, authorizing Class A and Class B common stock with Class B having 20 votes per share, and dividing the board into three classes with staggered three-year terms. | Upon IPO closing | Establishes a dual-class share structure concentrating voting power with pre-IPO stockholders and implements a staggered board, potentially impacting shareholder influence and takeover attempts. |
| Director Compensation Policy | A non-employee director compensation policy will be adopted, effective upon the execution of the underwriting agreement. | Upon underwriting agreement execution | Standardizes compensation for non-employee directors, aligning with public company practices. |
| Compensation Recovery (Clawback) Policy | A compensation recovery policy compliant with SEC rules and applicable stock exchange listing rules will be adopted. | Upon IPO closing | Enhances corporate accountability and aligns with regulatory requirements for public companies. |
| Code of Conduct & Anti-Harassment Policy | A code of conduct applicable to directors, officers, and employees, and an Anti-Harassment and Discrimination Policy will be adopted within 60 days of the Purchase Agreement closing date. | Within 60 days of Purchase Agreement closing date | Strengthens ethical standards and workplace environment, crucial for public company reputation and compliance. |
| Indemnification Agreements | Confirmatory offer letters and indemnification agreements will be entered into with directors and executive officers, providing for elimination of director liability and indemnification to the maximum extent permitted by Delaware law. | In connection with IPO | Protects directors and officers from liabilities, aiding in attracting and retaining qualified personnel, but may reduce avenues for shareholder lawsuits. |
| FCPA and Anti-Bribery Compliance | The company represents compliance with the U.S. Foreign Corrupt Practices Act of 1977, the U.K. Bribery Act, and other anti-bribery/anti-corruption laws, and will maintain internal controls. | Ongoing | Ensures legal and ethical business practices globally, mitigating regulatory and reputational risks. |
| Voting Agreement Termination | A voting agreement among certain stockholders (including 5% holders and co-founders) will terminate upon IPO closing. | Upon IPO closing | Removes pre-IPO voting arrangements, but concentrated voting power remains due to the dual-class structure. |
| Founder Voting Proxy | Co-founders Peter Colis and Lingke Wang will enter into a Founder Voting Proxy agreement, granting exclusive voting control over Class B shares to the non-Triggering co-founder upon a Triggering Event. | Upon IPO closing | Ensures continuity of leadership control by one co-founder in specific circumstances, reinforcing concentrated voting power. |
| Exclusive Forum Provisions | The amended and restated certificate of incorporation will designate the Court of Chancery of Delaware and federal district courts as exclusive forums for certain disputes. | Immediately prior to IPO closing | Aims to centralize litigation in specific jurisdictions, potentially limiting stockholders' choice of forum for disputes. |
Legal Proceedings
- Subject to litigation, regulatory investigations, and claims arising in the normal course of business operations.
- In 2022, the company was subject to class action litigation (since settled) and inquiries and investigations from various state regulators (since settled) due to a cyber incident where threat actors obtained consumer personal information from a third-party integration.
- Not presently a party to any litigation the outcome of which, if determined adversely, would individually or taken together have a material adverse effect on business, financial condition, results of operations, and cash flows.
Related Party Transactions
- Three executive officers (Erin Lantz, Kunal Mehta, and Vipul Sharma) sold shares of common stock in a March 2025 tender offer for $3,316,440.96, $1,504,287.36, and $4,425,966.72, respectively.
- The company is party to an amended and restated investors rights agreement with certain holders of redeemable convertible preferred stock, including entities affiliated with Accel Growth Fund IV L.P., GV 2019, L.P., and Sequoia Capital U.S. Venture Fund XV, L.P., each holding more than 5% of outstanding capital stock.
- The investors rights agreement provides registration rights, information rights (which will terminate upon the closing of this offering), and a right of first refusal (which will not apply to, and will terminate upon, the closing of this offering) with regard to certain issuances of capital stock.
- The company has a right of first refusal to purchase shares of capital stock from certain stockholders (including 5% holders and co-founders) under equity compensation plans and a co-sale agreement, which terminates upon the consummation of this offering.
- A voting agreement with certain stockholders (including 5% holders and co-founders) will terminate upon the closing of this offering.
- Co-founders Peter Colis and Lingke Wang will enter into a Founder Voting Proxy agreement.
- GC&H Investments, LLC, an entity comprised of partners and associates of Cooley LLP (legal counsel), beneficially owns 84,917 shares of Class A common stock issuable upon the conversion of convertible preferred stock.
Stakeholder Impact
- Shareholders: Potential for dilution from the IPO, RSU settlement, and future capital raises. Concentrated voting control with pre-IPO stockholders (co-founders, Accel, Sequoia). Potential for stock price volatility. Benefits from company growth and profitability.
- Employees: Eligible for equity awards (options, RSUs) as long-term incentives. Covered by the Severance Plan for severance benefits. Participate in a 401(k) plan. Potential for increased stock-based compensation expense.
- Customers (Consumers): Benefit from democratized access to life insurance, a faster digital application process, transparent pricing, high approval rates, and seamless servicing, as reflected by a high NPS score.
- Agents: Empowered with the Agent OS, instant policies, next-day commissions, loyalty programs, and productivity tools, leading to increased earning potential.
- Suppliers (Carriers): Gain expanded consumer and agent reach, optimized risk selection, profitable growth, and full-service policy administration through Ethos's modern technology.
- Creditors: The company has obligations related to the sale of commissions receivable, which could impact cash flows and financial planning.
Next Steps
- Complete the Initial Public Offering (IPO) process, including the registration statement becoming effective.
- List Class A common stock on the Nasdaq Global Select Market under the symbol LIFE.
- Launch two additional products: Cancer Insurance and Accumulation Indexed Universal Life Insurance by the end of 2025.
- Continue to invest in platform features to streamline the sales process and boost agent productivity.
- Continue to attract more consumers by leveraging data advantage.
- Continue to recruit more agents and increase Ethos's share of agents' sales.
- Continue to expand the product portfolio.
- Remediate the identified material weakness in internal control over financial reporting.
- Comply with Section 404 of the Sarbanes-Oxley Act by the year ending December 31, 2027.
Key Dates
| Date | Description |
|---|---|
| July 5, 2016 | Original Certificate of Incorporation filed (Ethos Insurance Corporation). |
| August 2016 | Name changed to Ethos Technologies Inc. |
| July 2, 2018 | Loan and Security Agreement with Silicon Valley Bank. |
| October 2018 | Roelof Botha and Nathan J. Niparko joined the board of directors. |
| July 9, 2019 | Amended and Restated Investor Rights Agreement. |
| July 2019 | John Kunze joined the board of directors. |
| April 2020 | Erin Lantz joined as Chief Revenue Officer. |
| December 11, 2020 | 2016 Equity Incentive Plan amended. |
| April 2021 | Priscilla Hung joined the board of directors. |
| April 29, 2021 | 2016 Equity Incentive Plan amended and approved by stockholders. |
| July 13, 2021 | Amended and Restated Investor Rights Agreement entered into; 2016 Equity Incentive Plan amended and approved by stockholders. |
| July 26, 2021 | Amended and Restated Investor Rights Agreement entered into. |
| July 2021 | Lingke Wang became President, Vipul Sharma became Chief Technology Officer. |
| August 29, 2022 | 2016 Equity Incentive Plan amended and approved by stockholders. |
| October 28, 2022 | Sub-Sublease Agreement with Landed, Inc. |
| January 1, 2023 | Adoption of ASU 2016-13. |
| January 20, 2023 | Consent to Sub-Sublease Agreement. |
| March 2023 | Kunal Mehta became Chief Financial Officer. |
| September 2023 | Indexed Universal Life Insurance product launched. |
| October 26, 2023 | 2016 Equity Incentive Plan amended. |
| November 2, 2023 | 2016 Equity Incentive Plan amendment approved by stockholders. |
| December 31, 2023 | Fiscal year end. |
| January 1, 2024 | Adoption of ASU 2023-07. |
| May 3, 2024 | Office Lease for 90 New Montgomery Street, San Francisco. |
| May 2024 | Company entered into a lease agreement in San Francisco, CA. |
| October 2024 | Ms. Lantz joined the board of directors of Meritage Homes Corporation. |
| December 2024 | Sold a portion of commissions receivable to an unaffiliated third-party re-insurer for upfront cash. |
| December 31, 2024 | Fiscal year end. |
| January 2025 | Issued fully vested warrants to a third party. |
| February 2025 | Completed a secondary sale of 496 shares of common stock from employees to new investors. |
| March 2025 | Facilitated a tender offer for employees. |
| April 2025 | Christopher Capozzi became Chief Financial Officer; Kunal Mehta became Senior Vice President, Finance. |
| April 2025 | Issued warrants to a third party. |
| May 2025 | CEO Peter Colis granted RSU award covering 1,854,134 shares. |
| May 23, 2025 | Severance Plan approved by the Board. |
| June 30, 2025 | End of interim financial period. |
| July 2025 | William J. Wheeler joined the board of directors. |
| September 22, 2025 | Severance Plan amended and restated by the Board. |
| September 25, 2025 | Seven-for-one reverse stock split effected. |
| September 26, 2025 | S-1 Registration Statement filed. |
| October 2025 | Term Life Insurance product with John Hancock expected to be offered through this month. |
| By end of 2025 | Plan to launch Cancer Insurance and Accumulation Indexed Universal Life Insurance. |
| January 1, 2026 | Annual automatic increase for 2025 Plan and 2025 ESPP begins. |
| July 4, 2026 | 2016 Plan automatically terminates. |
| November 2026 | Lease agreement in Bangalore, Karnataka, India expires. |
| December 31, 2027 | Section 404 audit requirements apply. |
| November 2028 | Principal executive offices lease in San Francisco expires. |
| January 1, 2035 | 2025 ESPP share reserve automatic increase ends. |
Recommendation
strong buyEthos Technologies demonstrates exceptional growth in a large, underserved market, coupled with a proven path to profitability and strong margins. Its vertically integrated, data-driven platform provides a significant competitive advantage, evidenced by high customer satisfaction (NPS of 70) and efficient product development. The company's ability to attract and retain both consumers and a growing network of agents, while deepening relationships with major carriers, positions it for continued market share expansion. While risks associated with growth, competition, and regulatory environment exist, the overall financial trajectory, innovative business model, and clear growth strategies make it a compelling investment opportunity for long-term growth. The planned product expansion into Cancer Insurance and Accumulation Indexed Universal Life Insurance further diversifies revenue streams and addresses broader market needs.
Keywords
Life insurance, Insurtech, Digital platform, Underwriting, Agent OS, SEC filing, IPO, Financial technology, Risk management, Corporate governance, Stock options, Restricted stock units, Capital raise, Nasdaq, Class A common stock, Class B common stock, Peter Colis, Lingke Wang, Sequoia Capital, Accel, GV, SoftBank
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.